这是一篇来自已证抗体库的有关
人类 Grb2的综述，是根据24篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Grb2 抗体。
Grb2 同义词: ASH; EGFRBP-GRB2; Grb3-3; MST084; MSTP084; NCKAP2; growth factor receptor-bound protein 2; HT027; SH2/SH3 adapter GRB2; abundant SRC homology; epidermal growth factor receptor-binding protein GRB2; growth factor receptor-bound protein 3; protein Ash
圣克鲁斯生物技术
| 小鼠 单克隆（E-1） | | 圣克鲁斯生物技术 Grb2抗体（Santa Cruz, sc-17813)被用于被用于免疫印迹在大鼠样品上. Front Neurosci (2016) ncbi |
| 小鼠 单克隆（C-7） | | 圣克鲁斯生物技术 Grb2抗体（Santa Cruz, sc-8034)被用于被用于免疫印迹在人类样品上浓度为1:200 (图 2). Oncol Lett (2016) ncbi |
| 小鼠 单克隆（1-68） | - 免疫沉淀; 人类; 图 2g
- 免疫细胞化学; 人类; 1:500; 图 s3h
- 免疫印迹; 人类; 1:1000; 图 5a
| 圣克鲁斯生物技术 Grb2抗体（Santa Cruz Biotechnology, sc-503)被用于被用于免疫沉淀在人类样品上 (图 2g), 被用于免疫细胞化学在人类样品上浓度为1:500 (图 s3h) 和 被用于免疫印迹在人类样品上浓度为1:1000 (图 5a). Nat Commun (2016) ncbi |
安迪生物R&D
| 小鼠 单克隆（669604） | | 安迪生物R&D Grb2抗体（R&D Systems, 669604)被用于被用于免疫印迹在人类样品上 (图 4s3). elife (2016) ncbi |
| 小鼠 单克隆（481021） | | 安迪生物R&D Grb2抗体（R&D systems, MAB3846)被用于被用于免疫印迹在人类样品上. Biochem Biophys Res Commun (2014) ncbi |
艾博抗（上海）贸易有限公司
| 兔 单克隆（Y301） | | 艾博抗（上海）贸易有限公司 Grb2抗体（Abcam, ab32111)被用于被用于免疫印迹在小鼠样品上浓度为1:2000. Acta Neuropathol (2015) ncbi |
武汉三鹰
| 兔 多克隆 | | 武汉三鹰 Grb2抗体（Proteintech Group, 10254-2-AP)被用于被用于免疫印迹在猪样品上 (图 5). Sci Rep (2017) ncbi |
LifeSpan Biosciences
| 兔 多克隆 | | LifeSpan Biosciences Grb2抗体（Lifespan Biosciences, LB-B4079)被用于被用于免疫细胞化学在人类样品上 (图 s1). J Cell Sci (2016) ncbi |
赛信通（上海）生物试剂有限公司
| 兔 多克隆 | | 赛信通（上海）生物试剂有限公司 Grb2抗体（Cell Signaling, 3972)被用于被用于免疫印迹在人类样品上 (图 4c). Cancer Res (2017) ncbi |
| 兔 多克隆 | | 赛信通（上海）生物试剂有限公司 Grb2抗体（Cell Signaling, 3972)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 2a). Nat Commun (2017) ncbi |
| 兔 多克隆 | | 赛信通（上海）生物试剂有限公司 Grb2抗体（Cell Signaling Technology, 3972S)被用于被用于免疫印迹在人类样品上 (图 8). J Biol Chem (2016) ncbi |
| 兔 多克隆 | | 赛信通（上海）生物试剂有限公司 Grb2抗体（Cell Signaling, 3972)被用于被用于免疫印迹在小鼠样品上 (图 5). Front Cell Neurosci (2016) ncbi |
碧迪BD
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Biosciences, 610112)被用于被用于免疫细胞化学在人类样品上 (图 s12). Mol Biol Cell (2016) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Biosciences, 610111)被用于被用于免疫印迹在人类样品上 (图 6b). Nat Struct Mol Biol (2016) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（Transduction Lab, 610111)被用于被用于免疫印迹在人类样品上. Sci Rep (2016) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Pharmingen, 610111)被用于被用于免疫印迹在人类样品上 (图 4). Mol Cancer (2015) ncbi |
| 小鼠 单克隆（81/GRB2） | - 免疫印迹; 人类; 图 2
- 免疫印迹; 小鼠; 图 1
| 碧迪BD Grb2抗体（BD Bioscience, 610111)被用于被用于免疫印迹在人类样品上 (图 2) 和 被用于免疫印迹在小鼠样品上 (图 1). Nat Med (2015) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Transduction Laboratories, 610112)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 2). Oncotarget (2015) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Biosciences, 610112)被用于被用于免疫印迹在人类样品上 (图 3). Nat Commun (2015) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Bioscience, 610112)被用于被用于免疫印迹在小鼠样品上 (图 2). Cancer Res (2015) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Transduction, 610112)被用于被用于免疫印迹在人类样品上 (图 4). J Cell Sci (2015) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD, 610112)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 5D). DNA Repair (Amst) (2015) ncbi |
| 小鼠 单克隆（81/GRB2） | - 免疫沉淀; 小鼠; 图 7
- 免疫印迹; 小鼠; 1:2000; 图 7
| 碧迪BD Grb2抗体（BD Transduction Laboratories, 610112)被用于被用于免疫沉淀在小鼠样品上 (图 7) 和 被用于免疫印迹在小鼠样品上浓度为1:2000 (图 7). PLoS ONE (2014) ncbi |
| 小鼠 单克隆（81/GRB2） | | 碧迪BD Grb2抗体（BD Biosciences, 610111)被用于被用于免疫印迹在人类样品上浓度为1:2000. FEBS Lett (2013) ncbi |
Vaishnavi A, Schubert L, Rix U, Marek L, Le A, Keysar S,
et al. EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases. Cancer Res. 2017;77:3551-3563
pubmed 出版商 Yang S, Pei Y, Zhao A. iTRAQ-based Proteomic Analysis of Porcine Kidney Epithelial PK15 cells Infected with Pseudorabies virus. Sci Rep. 2017;7:45922
pubmed 出版商 Luo L, Bokil N, Wall A, Kapetanovic R, Lansdaal N, Marceline F,
et al. SCIMP is a transmembrane non-TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages. Nat Commun. 2017;8:14133
pubmed 出版商 Pandini G, Satriano C, Pietropaolo A, Gianì F, Travaglia A, La Mendola D,
et al. The Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor. Front Neurosci. 2016;10:569
pubmed 出版商 Yi J, Manna A, Barr V, Hong J, Neuman K, Samelson L. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell. 2016;27:3591-3600
pubmed Sousa A, Rei M, Freitas R, Ricardo S, Caffrey T, David L,
et al. Effect of MUC1/?-catenin interaction on the tumorigenic capacity of pancreatic CD133+ cells. Oncol Lett. 2016;12:1811-1817
pubmed Liu L, Phua Y, Lee R, Ma X, Jenkins Y, Novy K,
et al. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. J Biol Chem. 2016;291:21571-21583
pubmed Daubon T, Spuul P, Alonso F, Fremaux I, Genot E. VEGF-A stimulates podosome-mediated collagen-IV proteolysis in microvascular endothelial cells. J Cell Sci. 2016;129:2586-98
pubmed 出版商 Francavilla C, Papetti M, Rigbolt K, Pedersen A, Sigurdsson J, Cazzamali G,
et al. Multilayered proteomics reveals molecular switches dictating ligand-dependent EGFR trafficking. Nat Struct Mol Biol. 2016;23:608-18
pubmed 出版商 Jadwin J, Oh D, Curran T, Ogiue Ikeda M, Jia L, White F,
et al. Time-resolved multimodal analysis of Src Homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases. elife. 2016;5:e11835
pubmed 出版商 Osinalde N, Sánchez Quiles V, Blagoev B, Kratchmarova I. Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes. Sci Rep. 2016;6:23530
pubmed 出版商 Zhang X, Peng D, Xi Y, Yuan C, Sagum C, Klein B,
et al. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression. Nat Commun. 2016;7:10810
pubmed 出版商 Balakrishnan S, Niebert M, Richter D. Rescue of Cyclic AMP Mediated Long Term Potentiation Impairment in the Hippocampus of Mecp2 Knockout (Mecp2(-/y) ) Mice by Rolipram. Front Cell Neurosci. 2016;10:15
pubmed 出版商 van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, Van Ijcken W, Mathijssen R,
et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196
pubmed 出版商 Wen Q, Yang Q, Goldenson B, Malinge S, Lasho T, Schneider R,
et al. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med. 2015;21:1473-80
pubmed 出版商 Xing M, Wang X, Palmai Pallag T, Shen H, Helleday T, Hickson I,
et al. Acute MUS81 depletion leads to replication fork slowing and a constitutive DNA damage response. Oncotarget. 2015;6:37638-46
pubmed 出版商 Capuani F, Conte A, Argenzio E, Marchetti L, Priami C, Polo S,
et al. Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells. Nat Commun. 2015;6:7999
pubmed 出版商 Kratochvill F, Gratz N, Qualls J, Van De Velde L, Chi H, Kovarik P,
et al. Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner. Cancer Res. 2015;75:3054-64
pubmed 出版商 Parodi B, Rossi S, Morando S, Cordano C, Bragoni A, Motta C,
et al. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathol. 2015;130:279-95
pubmed 出版商 Diesenberg K, Beerbaum M, Fink U, Schmieder P, Krauss M. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR. J Cell Sci. 2015;128:397-407
pubmed 出版商 Uringa E, Baldeyron C, Odijk H, Wassenaar E, van Cappellen W, Maas A,
et al. A mRad51-GFP antimorphic allele affects homologous recombination and DNA damage sensitivity. DNA Repair (Amst). 2015;25:27-40
pubmed 出版商 Tao W, Moore R, Smith E, Xu X. Hormonal induction and roles of Disabled-2 in lactation and involution. PLoS ONE. 2014;9:e110737
pubmed 出版商 Kim K, Lee S, Ryu S, Han D. Efficient isolation and elution of cellular proteins using aptamer-mediated protein precipitation assay. Biochem Biophys Res Commun. 2014;448:114-9
pubmed 出版商 Kodigepalli K, Dutta P, Bauckman K, Nanjundan M. SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells. FEBS Lett. 2013;587:5-16
pubmed 出版商
